Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer
Akamatsu, Hiroaki, Murakami, Eriko, Oyanagi, Jun, Shibaki, Ryota, Kaki, Takahiro, Takase, Eri, Tanaka, Masanori, Harutani, Yuhei, Yamagata, Nao, Okuda, Yuka, Furuta, Katsuyuki, Sugimoto, Takeya, TeraoLanguage:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2019-0299
Date:
November, 2019
File:
PDF, 484 KB
english, 2019